Answers are grounded in this paper and cite their sources.
Background Constipation, which is common in patients receiving palliative care, reduces quality of life and pain control. Ultrasound aids in diagnosis and treatment monitoring; however, evidence on managing rectal fecal retention is lacking. We aimed to compare the effectiveness of transanal (TA) and transoral (TO) treatments for rectal fecal retention diagnosed using point-of-care ultrasound. Methods A prospective observational study was conducted from July 2023 to July 2024, at the International University of Health and Welfare Narita Hospital, Japan. Forty-two newly registered palliative care inpatients with rectal fecal retention were enrolled. Twenty-one participants received TA treatment (bisacodyl 10 mg or sodium bicarbonate and anhydrous sodium dihydrogen phosphate once) and 21 received TO treatment (sennoside 24 mg once). The primary outcome was defecation rate within 24 h. Secondary outcomes included improvement rate in incomplete evacuation, loss of defecation desire (LODD) within 24 h, and treatment satisfaction. Results Defecation within 24 h occurred in 71% of patients in the TA group versus 33% in the TO group ( P = 0.01). Improvement in a sense of incomplete evacuation was achieved in 80% and 24% of patients in the TA and TO groups, respectively ( P = 0.001). LODD improved in 67% of patients in the TA group versus 31% in the TO group ( P = 0.049); treatment satisfaction was higher in the TA group (62%) than in the TO group (24%; P = 0.01). Conclusions TA treatment may be associated with improved bowel-related outcomes than TO treatment for rectal fecal retention in palliative care settings.
No takes yet. Share an insight, caveat, or question.
Sugimoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: